What is the optimal biological therapy for moderate to severe ulcerative colitis: a systematic review and network meta-analysis
ObjectiveThe biologics for moderate to severe ulcerative colitis (UC) have expanded with an increasing array. We performed an updated network meta-analysis to evaluate and compare the relative efficacy and safety profiles of biologics in moderate to severe UC.DesignWe searched literature to 18 May 2...
Saved in:
| Main Authors: | Longbin Huang, Chen Kong, Ningning Yue, Hailan Zhao, Yuan Zhang, Chengmei Tian, Zhiliang Mai, Daoru Wei, Ruiyue Shi, Jun Yao, Lisheng Wang, Defeng Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1602024/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world of Limosilactobacillus reuteri in mitigation of acute experimental colitis
by: Ningning Yue, et al.
Published: (2025-01-01) -
Advances in surgical treatment of ulcerative colitis associated colorectal cancer
by: He-Yuan NIU, et al.
Published: (2023-12-01) -
Molecular Mechanisms and Clinical Aspects of Colitis-Associated Cancer in Ulcerative Colitis
by: Jesus K. Yamamoto-Furusho, et al.
Published: (2025-01-01) -
Efficacy and safety of vedolizumab in elderly and younger patients with moderate-to-severe ulcerative colitis: a retrospective real-world study in China
by: Hao Zhang, et al.
Published: (2025-07-01) -
Malignant perforation of sigmoid colon in long-standing ulcerative colitis
by: G K Adithya, et al.
Published: (2020-01-01)